AI in healthcare that protects patients, clinicians and PHI from day one

AI in healthcare has to be safe before it is fast. We design the platforms, data flows and clinical governance that let health systems, payers and life sciences companies put AI into real workflows while meeting HIPAA, FDA and patient safety obligations.

Book a briefing

Exterior of a modern hospital building with a glass and steel facade

What is different about AI in healthcare and life sciences

AI in healthcare touches the most sensitive data most people have, and some of it influences decisions about their care. That combination changes the architecture. Protected health information needs contractual, technical and audit controls at every hop, and any output that could reach a clinical decision needs evaluation that clinicians, not just engineers, accept.

The regulatory picture is layered. HIPAA governs how PHI is used and disclosed. FDA oversight can apply when software is intended to diagnose, treat or inform clinical management in ways a clinician cannot independently review. Health IT certification rules add transparency expectations for decision support, and life sciences companies bring GxP validation and data integrity requirements to anything that touches regulated records.

The good news is that the highest-value opportunities are often administrative and documentation work: prior authorization, clinical documentation, coding, patient messaging, medical information and regulatory writing. These deliver real relief to overloaded staff and can be designed with a human firmly in the loop while the organization builds its clinical AI governance.

Where AI earns its place

Ambient clinical documentation

Draft visit notes from recorded encounters for clinician review and signature inside the EHR. The architecture covers patient consent, audio retention limits, specialty-specific evaluation and monitoring of edit rates so documentation quality is measured, not assumed.

Prior authorization and utilization review

Assemble clinical evidence from the chart against payer criteria and draft the submission or review summary. Determinations stay with qualified reviewers, and every cited fact links back to the source note so reviewers can verify before acting.

Patient message drafting

Draft replies to portal messages for clinicians and care teams to edit and send, with triage that routes urgent symptoms to people immediately. Drafts are never sent without review, and the system logs which drafts were used or rewritten.

Revenue cycle and coding support

Suggest codes with supporting documentation excerpts, identify missing documentation before claims go out and summarize denials for appeal. Coders confirm every code, and suggestion accuracy is audited against certified coder review on a regular sample.

Medical information and regulatory writing

For life sciences teams, retrieval over approved labeling, clinical study reports and standard responses to draft medical information replies and regulatory documents. Content stays within approved sources, with medical and regulatory review before anything is released.

Clinical trial operations

Screen protocol eligibility criteria against structured and unstructured records to support site feasibility and recruitment, and summarize protocol deviations. Outputs support study teams and investigators; they do not replace investigator judgment on enrollment.

The regulatory and safety constraints we design for

Healthcare AI sits across several regimes at once. We identify which ones apply to each use case early, because the answer changes the architecture, the evaluation plan and sometimes the product strategy.

HIPAA Privacy and Security Rules: Any vendor that creates, receives or processes PHI on your behalf, including model providers, needs a business associate agreement. We design minimum necessary data access, de-identification where it works, encryption, audit logging and provider terms that prohibit training on your data.
FDA oversight of software as a medical device: Software intended to diagnose, treat or drive clinical management can be a regulated device. FDA guidance on clinical decision support software and on predetermined change control plans for AI-enabled devices shapes whether and how a use case is built. We make intended use explicit early.
Information blocking (21st Century Cures Act): The Cures Act information blocking rules limit practices that interfere with access, exchange or use of electronic health information. AI systems and data platforms must not become new barriers to patient or authorized access, and data architecture should support required exchange.
Health IT decision support transparency: ONC health IT certification rules introduced transparency expectations for predictive decision support interventions in certified EHR technology. Health systems should expect vendors to disclose source attributes and should keep equivalent documentation for AI they build themselves.
Nondiscrimination in patient care tools: HHS rules under Section 1557 of the Affordable Care Act address discrimination through patient care decision support tools. We build bias evaluation across patient populations into clinical AI testing and monitoring, with documented mitigation when disparities appear.
GxP and data integrity in life sciences: AI that touches regulated records in clinical, manufacturing or pharmacovigilance processes falls under computerized system validation and data integrity expectations, including 21 CFR Part 11 where electronic records and signatures apply. We design risk-based validation that works with models that change.

How we architect AI for healthcare organizations

We classify every use case by data sensitivity and clinical impact before choosing technology. Administrative work with PHI, clinician-facing drafting, and anything near clinical decision-making each get a different control set. That classification decides which model endpoints are allowed, what human review is mandatory and how much clinical evaluation is required before launch.

PHI stays inside a controlled boundary. Models run on endpoints covered by business associate agreements, in your cloud tenancy or through private connectivity, behind a gateway that logs access in a form your privacy office can audit. Retrieval respects EHR roles and break-the-glass rules instead of flattening access into a single index.

Integration follows the EHR, not the other way around. We design around FHIR APIs, vendor integration frameworks and existing clinician workflows so that AI appears where the work happens. Tools that require a separate window and a separate login rarely survive past the pilot.

Evaluation involves clinicians. For each use case we build test sets reviewed by practicing clinicians, measure factual accuracy, omissions and harmful suggestions separately, check performance across patient populations, and keep monitoring after launch. That evidence is what a clinical AI governance committee needs to approve AI in healthcare workflows with confidence.

AI in healthcare and life sciences: common questions

Is it HIPAA compliant to use large language models with patient data?

It can be. Using LLMs with protected health information requires a business associate agreement with the model provider, a service configuration that does not retain or train on your data, access controls based on minimum necessary use, encryption and audit logging. Several major cloud AI services offer HIPAA-eligible configurations, but eligibility alone does not make a specific deployment compliant.

When does healthcare AI need FDA clearance?

Healthcare AI may need FDA clearance when it is intended to diagnose, treat, mitigate or prevent disease, or to drive clinical management in ways a clinician cannot independently review. Administrative tools and many documentation aids generally fall outside device regulation. The deciding factor is intended use, so define and document it before building, and get regulatory counsel involved early.

How should a health system govern clinical AI?

A health system should govern clinical AI through a multidisciplinary committee with clinical, informatics, privacy, security, legal and equity representation. The committee approves use cases by risk tier, reviews evaluation evidence before launch, requires monitoring after launch and owns the AI inventory. It should cover vendor AI embedded in the EHR as well as tools built internally.

What are the safest first AI use cases in healthcare?

The safest first AI use cases in healthcare are administrative and documentation tasks with mandatory human review, such as drafting patient message replies, summarizing charts for prior authorization, coding suggestions and policy search. They reduce staff burden, keep a clinician or qualified reviewer accountable for every output, and let the organization build governance and evaluation muscle before higher-risk clinical uses.

How do life sciences companies validate AI under GxP?

Life sciences companies validate AI under GxP with a risk-based approach: define intended use, assess impact on product quality and patient safety, and scale testing to that risk. For generative AI, validation relies on documented evaluation sets, acceptance criteria, human review steps, version control of models and prompts, and change control that triggers re-testing when anything changes.

Other industries

In the capital region? We are based in Rockville, Maryland, and run architecture workshops in person. See enterprise AI consulting in Washington DC, Maryland and Virginia.

Bring us the architecture question you are stuck on.

Kelsey, our AI assistant, can answer questions and book you a 30-minute briefing with a senior architect in about two minutes, by voice or by typing.

Vendor-neutral advice. We resell nothing.
Senior architects on the call, not a sales team.
Mutual NDA available before we talk specifics.

Book with Kelsey

She finds a time that works, books it on our calendar and sends the invite. No forms.

By talking or chatting with Kelsey, you agree we may text and email you about your request. Message and data rates may apply. Reply STOP to opt out. Terms and Privacy.

Prefer a person? Call (301) 301-5765.